PARP1 and acute myeloid leukemia: The presence/absence of two key parthanatos features, PARP-dependent changes in drug sensitivity and characteristic nuclear “ring” morphologies, are highly correlated (χ2(3) = 29.1, p ≤ 0.0001) in samples taken from 39 patients with AML of FAB subtypes M4+M5.